Showing 1 - 7 results of 7 for search 'Joan M. Lappe', query time: 0.03s Refine Results
  1. 1
    A pilot study on the nanoscale properties of bone tissue near lacunae in fracturing women

    A pilot study on the nanoscale properties of bone tissue near lacunae in fracturing women by Wen Qian, Roman Schmidt, Joseph A. Turner, Sue P. Bare, Joan M. Lappe, Robert R. Recker, Mohammed P. Akhter

    Published 2022-12-01
    Get full text
    Article
  2. 2
    MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis.

    MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. by Yang Wang, Ling Li, Benjamin T Moore, Xian-Hao Peng, Xiang Fang, Joan M Lappe, Robert R Recker, Peng Xiao

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Influence of anthropometric parameters on assessment of pediatric bone mineral density and bone mineral content

    Influence of anthropometric parameters on assessment of pediatric bone mineral density and bone mineral content by David F. Short, Thomas N. Hangartner, Vicente Gilsanz, Heidi J. Kalkwarf, Joan M. Lappe, Sharon Oberfield, John A. Shepherd, Babette S. Zemel, Karen Winer

    Published 2014-10-01
    Get full text
    Article
  4. 4
    Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.

    Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study. by Sharon L McDonnell, Carole Baggerly, Christine B French, Leo L Baggerly, Cedric F Garland, Edward D Gorham, Joan M Lappe, Robert P Heaney

    Published 2016-01-01
    Get full text
    Article
  5. 5
    Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.

    Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study. by Sharon L McDonnell, Carole Baggerly, Christine B French, Leo L Baggerly, Cedric F Garland, Edward D Gorham, Joan M Lappe, Robert P Heaney

    Published 2018-01-01
    Get full text
    Article
  6. 6
    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.

    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective coho... by Sharon L McDonnell, Carole A Baggerly, Christine B French, Leo L Baggerly, Cedric F Garland, Edward D Gorham, Bruce W Hollis, Donald L Trump, Joan M Lappe

    Published 2018-01-01
    Get full text
    Article
  7. 7
    CYP11B1 variants influence skeletal maturation via alternative splicing

    CYP11B1 variants influence skeletal maturation via alternative splicing by Olja Grgic, Matthew R. Gazzara, Alessandra Chesi, Carolina Medina-Gomez, Diana L. Cousminer, Jonathan A. Mitchell, Vid Prijatelj, Jard de Vries, Enisa Shevroja, Shana E. McCormack, Heidi J. Kalkwarf, Joan M. Lappe, Vicente Gilsanz, Sharon E. Oberfield, John A. Shepherd, Andrea Kelly, Soroosh Mahboubi, Fabio R. Faucz, Richard A. Feelders, Frank H. de Jong, Andre G. Uitterlinden, Jenny A. Visser, Louis R. Ghanem, Eppo B. Wolvius, Leo J. Hofland, Constantine A. Stratakis, Babette S. Zemel, Yoseph Barash, Struan F. A. Grant, Fernando Rivadeneira

    Published 2021-11-01
    Get full text
    Article

Search Tools: